...A. We have over 3,000 employees and 35 locations globally. B. The company in total had last year, $1.1 billion in revenues. C. 10% from net revenue is related to sales of instrumentation, 7.2% related to serve as a royalty, but most impressive is the 81% of our revenues related to consumables. D. Out of the 81%, 10% is related to consumables directly linked to the instruments, meaning cartridges, consumables that fit only on the instruments that we sell. E. We have two operating segments, Protein Sciences and the Diagnostics and Genomics segment. F. You see on the top left here, the Protein Sciences segment is the Lion's share of our business, 74% of the revenues related to the segment, 26% related to DGS. G. So 44% of the Bio-Techne revenue is related to the core in protein sciences, and then you have 7% related to cell and gene therapy and 23% related to the Proteome analytical instrumentation. H. On the DGS side, you see 12% related to the core and then 5% and 9%related to liquid biopsy...
